id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-1795-0001,FDA,FDA-2014-N-1795,Mallinckrodt Inc. et al.; Withdrawal of Approval of 23 New Drug Applications and 68 Abbreviated New Drug Applications,Notice,Withdrawal,2014-12-05T05:00:00Z,2014,12,2014-12-05T05:00:00Z,,2014-12-05T15:11:49Z,2014-28541,0,0,090000648195e55c